Teach me everything I need to know as an MBBS student in ANS Pharmacology

Reading File
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Reading File
Reading File
Reading File
Finding Sources
Finding Sources
Finding Sources
Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
Here is your complete MBBS-level ANS Pharmacology guide, synthesized from Lippincott Illustrated Reviews: Pharmacology and Katzung's Basic & Clinical Pharmacology.

🧠 ANS Pharmacology β€” Complete MBBS Guide


PART 1 β€” ANATOMY & PHYSIOLOGY REVIEW

Organization of the ANS

The ANS regulates involuntary visceral function β€” heart, smooth muscle, glands β€” without conscious control. It is also called the visceral, vegetative, or involuntary nervous system.
Two-neuron pathway:
  • Preganglionic neuron β†’ cell body in CNS β†’ exits to a ganglion
  • Postganglionic neuron β†’ cell body in ganglion β†’ innervates effector organ
FeatureSympatheticParasympathetic
OriginThoracolumbar (T1–L2)Craniosacral (CN 3, 7, 9, 10 + S2–S4)
Ganglia locationParavertebral / prevertebral chains (distant)In/near target organ (close)
Pre:Post fiber ratio1:many (divergence)1:1 (discrete)
Primary NT (preganglionic)ACh (nicotinic)ACh (nicotinic)
Primary NT (postganglionic)NorepinephrineACh (muscarinic)
ExceptionsSweat glands & some vasodilators β†’ ACh (muscarinic); Adrenal medulla β†’ Epi/NE into bloodβ€”
Adrenal medulla = modified sympathetic ganglion. Receives preganglionic cholinergic fibers β†’ secretes 80% epinephrine + 20% NE directly into blood.

Functional Effects (Fight-or-Flight vs Rest-and-Digest)

OrganSympathetic EffectParasympathetic Effect
Heart rate↑ (Ξ²1)↓ (M2)
Heart contractility↑ (Ξ²1)↓ (atria only, M2)
Blood vessels (skin/viscera)Constriction (Ξ±1)β€”
Blood vessels (skeletal muscle)Dilation (Ξ²2)β€”
BronchiolesDilation (Ξ²2)Constriction (M3)
GI motility↓ (Ξ±2, Ξ²2)↑ (M3)
GI sphinctersContract (Ξ±1)Relax (M3)
PupilsDilation β€” mydriasis (Ξ±1)Constriction β€” miosis (M3)
Lens (ciliary muscle)Relaxes β†’ far vision (Ξ²2)Contracts β†’ near vision (M3)
Urinary bladder (detrusor)Relaxes (Ξ²2)Contracts (M3)
Urinary sphincterContracts (Ξ±1)Relaxes (M3)
Salivary glandsThick, scant secretion (Ξ±1)Watery, profuse secretion (M3)
Sweat glandsSweating (M β€” sympathetic cholinergic)β€”
EjaculationYes (Ξ±1)Erection (M)
LiverGlycogenolysis/gluconeogenesis (Ξ²2, Ξ±1)Glycogen synthesis
KidneyRenin release (Ξ²1)β€”

PART 2 β€” NEUROTRANSMITTER PHYSIOLOGY

Cholinergic Transmission (6 Steps)

  1. Synthesis: Choline + Acetyl-CoA β†’ ACh (enzyme: choline acetyltransferase)
  2. Storage: Packaged into vesicles by VAChT (vesicular ACh transporter)
  3. Release: Action potential β†’ Ca²⁺ influx β†’ exocytosis
  4. Receptor binding: ACh binds muscarinic or nicotinic receptors
  5. Degradation: Acetylcholinesterase (AChE) cleaves ACh β†’ choline + acetate in synaptic cleft
  6. Recycling: Choline taken back up into neuron by choline transporter
Key drug target: AChE inhibitors block step 5 β†’ prolong ACh action

Adrenergic Transmission (4 Steps)

  1. Synthesis: Tyrosine β†’ DOPA (rate-limiting step: tyrosine hydroxylase) β†’ Dopamine β†’ NE
  2. Storage: Dopamine transported into vesicles by VMAT (vesicular monoamine transporter) β€” blocked by reserpine
  3. Release: Action potential β†’ Ca²⁺ influx β†’ exocytosis
  4. Termination:
    • Reuptake (Uptake-1) into neuron β€” major mechanism β€” blocked by cocaine, TCAs
    • MAO (intraneuronal) β€” degrades NE
    • COMT (extraneuronal/synaptic cleft) β€” methylates catecholamines
    • Final metabolite: VMA (vanillylmandelic acid) β€” excreted in urine (useful in diagnosing pheochromocytoma)

PART 3 β€” RECEPTORS

Cholinergic Receptors

ReceptorTypeLocationEffect
Nicotinic (NM)Ion channel (Na⁺/K⁺)Neuromuscular junctionSkeletal muscle contraction
Nicotinic (NN)Ion channelAutonomic ganglia, adrenal medulla, CNSFast EPSP, ganglion activation
Muscarinic M1Gq β†’ IP3/DAGCNS, gastric parietal cells↑ cognition, ↑ gastric acid
Muscarinic M2Gi β†’ ↓cAMPHeart (SA/AV node)↓ HR, ↓ AV conduction
Muscarinic M3Gq β†’ IP3/DAGSmooth muscle, glands, eyeContraction, secretion, miosis
Mnemonic: M1 = CNS/stomach; M2 = heart ("2 = two-pump organ"); M3 = smooth muscle/glands ("3 = three systems")

Adrenergic Receptors (Adrenoceptors)

ReceptorG-proteinSecond MessengerLocationEffect
Ξ±1Gq↑IP3/DAG β†’ ↑Ca²⁺Vascular smooth muscle, iris, prostate, bladder sphincterVasoconstriction, mydriasis, urinary retention
Ξ±2Gi↓cAMPPresynaptic nerve terminals, CNS, pancreatic Ξ²-cells↓NE release (autoreceptor), ↓insulin, sedation
Ξ²1Gs↑cAMPHeart, kidney (JGA)↑HR, ↑contractility, ↑renin
Ξ²2Gs↑cAMPBronchi, uterus, skeletal muscle vessels, liverBronchodilation, uterine relaxation, vasodilation
Ξ²3Gs↑cAMPAdipose tissue, bladder detrusorLipolysis, bladder relaxation
D1Gs↑cAMPRenal/mesenteric vasculatureVasodilation
D2Gi↓cAMPPresynaptic adrenergic neurons↓NE release
Agonist potency ranking:
  • Ξ± receptors: Epi β‰₯ NE >> Isoproterenol
  • Ξ² receptors: Isoproterenol > Epi > NE

PART 4 β€” CHOLINERGIC DRUGS

A. Direct-Acting Cholinergic Agonists

Choline Esters

DrugRouteSelectivityKey Uses
AcetylcholineOphthalmic (intraocular)M + NMiosis during ocular surgery
BethanecholOral, SCM onlyUrinary retention (post-op, neurogenic bladder), ↑GI motility. Not hydrolyzed by AChE
CarbacholOphthalmicM + NGlaucoma, miosis in surgery
MethacholineInhaledM onlyBronchoprovocation test for asthma diagnosis
Bethanechol key fact: Selective M agonist, resistant to AChE β†’ preferred for GI/urinary use. CI in asthma, peptic ulcer, obstruction.

Alkaloids

DrugKey UsesNotes
PilocarpineGlaucoma (reduces IOP), SjΓΆgren syndrome (dry mouth/eyes), xerostomiaPenetrates CNS; most important ophthalmic cholinergic
NicotineSmoking cessationLow dose β†’ ganglionic stimulation; High dose β†’ ganglionic block (depolarization block)
MuscarineMushroom poisoning (Clitocybe, Inocybe)No therapeutic use
CevimelineSjΓΆgren syndromeLonger acting than pilocarpine

B. Indirect-Acting Cholinergic Agonists (AChE Inhibitors)

Reversible AChE Inhibitors

DrugCNS penetrationDurationKey UsesNotes
PhysostigmineYesShortAtropine/anticholinergic overdoseNatural alkaloid; tertiary N
NeostigmineNo (quaternary N)30 min–2 hrMyasthenia gravis, reverse NMB, post-op urinary/GI atonyGreater NMJ effect than physostigmine
PyridostigmineNo3–6 hrChronic myasthenia gravis managementLonger acting than neostigmine
EdrophoniumNoVery short (5–10 min)Tensilon test β€” diagnosis of myasthenia gravisNo carbamylation; electrostatic binding only
DonepezilYesLong (24 hr)Alzheimer diseaseSelective CNS AChE inhibitor
RivastigmineYesIntermediateAlzheimer, Parkinson dementiaAlso inhibits butyrylcholinesterase
GalantamineYesβ€”Alzheimer diseaseAlso allosterically potentiates nicotinic receptors
TacrineYesβ€”Alzheimer (obsolete)Withdrawn due to hepatotoxicity

Irreversible AChE Inhibitors (Organophosphates)

DrugUses
EchothiophateGlaucoma (ophthalmic drops)
Sarin, VX, TabunChemical warfare agents
Malathion, ParathionAgricultural insecticides
Mechanism: Form covalent bond with AChE serine β†’ "aging" if not treated promptly (permanent inactivation)
Organophosphate poisoning features (SLUDGE + DUMBELS):
  • Salivation, Lacrimation, Urination, Defecation, GI distress, Emesis
  • Diaphoresis, Urination, Miosis, Bradycardia, Bronchospasm/bronchorrhea, Emesis, Lacrimation, Salivation
  • Muscle fasciculations β†’ weakness β†’ paralysis (NMJ overactivation)
  • CNS: anxiety, seizures, coma
Treatment of OP poisoning:
  1. Atropine β€” blocks muscarinic effects (high doses needed) β€” endpoint is drying of secretions
  2. Pralidoxime (2-PAM) β€” reactivates AChE before aging occurs (within ~24–48 hours); does NOT reverse CNS effects (quaternary, can't cross BBB)
  3. Benzodiazepines β€” for seizures

PART 5 β€” ANTICHOLINERGIC DRUGS (Muscarinic Antagonists)

Antimuscarinic Agents β€” Overview

These block M receptors only (not nicotinic), leaving sympathetic tone unopposed.
Classic mnemonic for atropine effects:
"Hot as a hare, Dry as a bone, Red as a beet, Blind as a bat, Mad as a hatter, Full as a flask"
EffectExplanation
↑ Heart rate (tachycardia)Block M2 on SA node
↓ Secretions (dry mouth, anhidrosis)Block M3 on glands
Mydriasis + cycloplegiaBlock M3 on iris/ciliary muscle
Constipation, urinary retentionBlock M3 on GI/bladder
CNS effects (confusion, hallucinations)With tertiary amines that cross BBB
Flushing (vasodilation)Mechanism unclear, possibly loss of cholinergic vasodilation in skin

Key Antimuscarinics

DrugPropertiesUses
AtropineTertiary amine, crosses BBB, non-selective M blockerBradycardia, organophosphate poisoning, pre-anesthetic (dry secretions), ophthalmic (mydriasis, cycloplegia), antidiarrheal
ScopolamineTertiary, strong CNS effectsMotion sickness (transdermal patch), pre-anesthetic, short-term amnesia
IpratropiumQuaternary (no CNS effects), inhaledCOPD (bronchodilation), rhinorrhea
TiotropiumQuaternary, long-acting (24 hr), inhaledCOPD (maintenance)
GlycopyrrolateQuaternary, no CNS effectsPre-anesthetic, peptic ulcer, hyperhidrosis
Benztropine / TrihexyphenidylTertiary, CNS activeParkinson disease (reduces tremor/rigidity)
Oxybutynin / Tolterodine / SolifenacinSelective M3 blockersOveractive bladder (OAB)
DarifenacinM3 selectiveOAB (less cognitive side effects)
Tropicamide / CyclopentolateShort actingOphthalmic (mydriasis/refraction)
CI for antimuscarinics: Angle-closure glaucoma, BPH, myasthenia gravis, paralytic ileus

Ganglionic Blockers

  • Mecamylamine, Trimethaphan β€” Block NN receptors at ganglia
  • Rarely used clinically; historically for hypertensive emergencies
  • Block BOTH sympathetic and parasympathetic ganglia β†’ unpredictable effects

Neuromuscular Blocking Agents (NMJ Blockers)

TypeDrugsMechanismReversal
DepolarizingSuccinylcholinePersistent activation of NM nicotinic receptor β†’ depolarization block; Phase I β†’ Phase II blockNo pharmacologic reversal; succinylcholinesterase (plasma ChE) hydrolyzes it
Non-depolarizing (competitive)Rocuronium, Vecuronium, Pancuronium, Cisatracurium, MivacuriumCompetitive block of NM nicotinic receptorNeostigmine (+ atropine to prevent bradycardia), or Sugammadex (for rocuronium/vecuronium)
Succinylcholine contraindications: Burns, crush injury, hyperkalemia risk, pseudocholinesterase deficiency (prolonged apnea), malignant hyperthermia (with volatile anesthetics)

PART 6 β€” ADRENERGIC DRUGS

A. Adrenergic Agonists (Sympathomimetics)

Classification:
  1. Direct-acting β€” bind adrenoceptors directly
  2. Indirect-acting β€” stimulate NE release or block reuptake
  3. Mixed-acting β€” both direct and indirect (e.g., ephedrine)

Catecholamines (direct-acting)

Cannot cross BBB (polar); not orally active (metabolized by MAO/COMT); short duration
DrugΞ±1Ξ±2Ξ²1Ξ²2Key Uses
Epinephrine+++++++++++Anaphylaxis (1st line), cardiac arrest (ACLS), adjunct to local anesthetics (prolongs action), acute asthma (SC)
Norepinephrine+++++++0Septic shock (vasopressor), ↑BP. Causes reflex bradycardia (baroreceptor)
Dopamine++ (high dose)β€”++β€”Shock: D1 (renal vasodilation, low dose), Ξ²1 (inotropy, moderate dose), Ξ±1 (vasoconstriction, high dose)
Isoproterenol00++++++Heart block, bronchospasm (historical); tachycardia limits use
Dobutamine00+++ (selective)+Acute heart failure (↑cardiac output without major ↑HR or BP)

Non-catecholamine Sympathomimetics

DrugTypeUsesNotes
PhenylephrineDirect Ξ±1Nasal decongestant, hypotension (intraoperative), mydriasisNo Ξ² effects β†’ causes reflex bradycardia
ClonidineDirect Ξ±2 (central)Hypertension, ADHD, opioid/alcohol withdrawal, menopausal flushingReduces sympathetic outflow from CNS; rebound hypertension on abrupt withdrawal
Ξ±-MethyldopaIndirect Ξ±2 (central)Hypertension in pregnancy (drug of choice)Converted to Ξ±-methylNE β†’ stimulates central Ξ±2
Albuterol (Salbutamol)Direct Ξ²2Acute asthma (rescue), COPDShort-acting Ξ²2 agonist (SABA); inhaled
Salmeterol / FormoterolDirect Ξ²2COPD and asthma (maintenance)Long-acting Ξ²2 agonists (LABA); black box warning: do not use as monotherapy in asthma β€” increased asthma-related deaths
Terbutaline / RitodrineDirect Ξ²2Tocolysis (suppress premature labor)Uterine relaxation via Ξ²2
EphedrineMixed (Ξ± + Ξ²)Nasal decongestant, hypotension during spinal anesthesia, asthma (historical)Releases stored NE + direct action; crosses BBB; tachyphylaxis
PseudoephedrineMixedNasal decongestant (oral OTC)Precursor for illicit methamphetamine synthesis β†’ regulated OTC
AmphetamineIndirectADHD, narcolepsyReverses VMAT + DAT β†’ massive NE/DA release; CNS stimulant
CocaineIndirectTopical local anesthetic (ENT)Blocks reuptake (Uptake-1); vasoconstriction β†’ useful in nasal surgery
Dopamine dose-effect summary (clinical pearl):
  • Low (1–5 mcg/kg/min): D1 β†’ renal & mesenteric vasodilation
  • Moderate (5–10 mcg/kg/min): Ξ²1 β†’ ↑cardiac output
  • High (>10 mcg/kg/min): Ξ±1 β†’ vasoconstriction

B. Adrenergic Antagonists (Sympatholytics)

Ξ±-Blockers

DrugSelectivityReversibilityUses
PhentolamineΞ±1 + Ξ±2 (non-selective)ReversiblePheochromocytoma diagnosis/preoperative management, extravasation of NE/dopamine
PhenoxybenzamineΞ±1 + Ξ±2 (non-selective)Irreversible (covalent)Pheochromocytoma (pre-op)
PrazosinΞ±1 selectiveReversibleHypertension, BPH; first-dose syncope
Doxazosin / TerazosinΞ±1 selectiveReversibleBPH, hypertension; once daily
TamsulosinΞ±1A selective (urogenital)ReversibleBPH (minimal BP effect)
YohimbineΞ±2 selectiveReversibleResearch tool; sexual dysfunction (historical)
Epinephrine reversal (adrenaline reversal): Phentolamine (Ξ±-blocker) administered before epinephrine β†’ epinephrine's Ξ± effects are blocked, leaving only Ξ²2 vasodilation β†’ BP falls instead of rises. Classic pharmacology exam question.

Ξ²-Blockers

All Ξ²-blockers are competitive antagonists. Names end in "-olol" (except labetalol, carvedilol).
DrugSelectivityISAOtherUses
PropranololNon-selective (Ξ²1+Ξ²2)NoMembrane stabilizingHypertension, angina, arrhythmias, MI, thyrotoxicosis, tremor, migraine prophylaxis, portal hypertension
MetoprololΞ²1 selectiveNoβ€”Hypertension, heart failure, MI (cardioprotective)
AtenololΞ²1 selectiveNoβ€”Hypertension, angina, MI
EsmololΞ²1 selectiveNoUltra-short acting (tΒ½ = 9 min)Intraoperative/perioperative tachycardia, SVT
TimololNon-selectiveNoOphthalmicGlaucoma (↓aqueous humor production)
NadololNon-selectiveNoLong actingHypertension, angina
PindololNon-selectiveYesISA means partial agonismHypertension (less bradycardia)
LabetalolΞ±1 + Ξ² (non-selective)NoAlso blocks Ξ±1Hypertension in pregnancy, hypertensive emergencies
CarvedilolΞ±1 + Ξ² (non-selective)NoAntioxidant propertiesHeart failure (reduces mortality), hypertension
NebivololΞ²1 selectiveβ€”Releases NO β†’ vasodilationHypertension
CeliprololΞ²1 selective, Ξ²2 partial agonistYesβ€”Hypertension
Ξ²-Blocker adverse effects:
  • Bradycardia, AV block, ↓cardiac output
  • Bronchoconstriction (Ξ²2 block) β€” CI in asthma/COPD (use cardioselective if must)
  • Masking hypoglycemia symptoms (CI in brittle diabetics)
  • Fatigue, cold extremities, sexual dysfunction
  • Abrupt withdrawal β†’ rebound tachycardia, angina, MI β€” always taper
  • Metabolic: ↑triglycerides, ↑LDL (except carvedilol)
Ξ²-Blocker contraindications:
  • Asthma / reactive airways (relative)
  • Decompensated heart failure (acute)
  • Bradycardia/AV block (2nd/3rd degree)
  • Cocaine-induced chest pain (Ξ²-block leaves Ξ± vasospasm unopposed β†’ use phentolamine instead)

Mixed Ξ±/Ξ² Blockers

  • Labetalol β€” IV for hypertensive emergencies, hypertension in pregnancy
  • Carvedilol β€” Chronic heart failure, post-MI LV dysfunction

PART 7 β€” HIGH-YIELD COMPARISONS & EXAM PEARLS

Effect of Key Drugs on Heart Rate

DrugMechanismNet HR Effect
Epinephrine (low dose)Ξ²1 dominates↑ HR
Epinephrine (high dose)Ξ±1 β†’ ↑BP β†’ baroreceptor reflexSlight ↓ HR or unchanged
NorepinephrineΞ±1 β†’ ↑BP β†’ strong baroreceptor reflex↓ HR (reflex bradycardia)
PhenylephrineΞ±1 only β†’ ↑BP β†’ baroreceptor reflex↓ HR (reflex bradycardia)
IsoproterenolΞ²1 (direct) + Ξ²2 β†’ ↓BP (vasodilation)↑↑ HR (direct + reflex)
AtropineBlocks M2 on SA node↑ HR
Neostigmine↑ACh β†’ M2 activation↓ HR

Drug of Choice Summary

ConditionDrug
AnaphylaxisEpinephrine (IM, 1:1000)
Septic shock (vasopressor)Norepinephrine
Acute decompensated heart failureDobutamine
Asthma attack (acute)Salbutamol (inhaled SABA)
Asthma + COPD maintenanceLABA + inhaled corticosteroid
Tocolysis (preterm labor)Terbutaline or ritodrine
Hypertension in pregnancyMethyldopa / Labetalol
Pheochromocytoma (pre-op)Phenoxybenzamine (irreversible Ξ±-blocker)
BPH + hypertensionDoxazosin/Prazosin
BPH only (no BP effect needed)Tamsulosin
Myasthenia gravis (diagnosis)Edrophonium (Tensilon test)
Myasthenia gravis (treatment)Pyridostigmine
Alzheimer diseaseDonepezil (1st line AChE inhibitor)
Organophosphate poisoningAtropine + Pralidoxime
Glaucoma (open angle)Pilocarpine, Timolol, Latanoprost
Motion sicknessScopolamine (transdermal)
COPD (inhaled anticholinergic)Tiotropium
Overactive bladderOxybutynin, Tolterodine, Solifenacin
Parkinson tremor/rigidityBenztropine/Trihexyphenidyl
Reversal of NMB (non-depolarizing)Neostigmine + Atropine
Reversal of RocuroniumSugammadex (preferred)

Receptor Summary for Catecholamines

Ξ±1Ξ±2Ξ²1Ξ²2
Epinephrine+++++++++++++++
Norepinephrine+++++++++0/+
Dopamine+ (high dose)β€”++β€”
Isoproterenol00++++++++
Dobutamine00+++++
Phenylephrine+++000
Clonidine0++++00
Albuterol000++++

PART 8 β€” CLINICAL SCENARIOS (Exam-Focused)

Q: Patient with asthma gets propranolol β€” what happens? Ξ²2 block β†’ bronchoconstriction β†’ dangerous. Use cardioselective Ξ²1 blocker (metoprolol) if absolutely necessary.
Q: NE infusion extravasates into arm tissue β€” treatment? Phentolamine (Ξ±-blocker) injected locally to reverse vasoconstriction and prevent necrosis.
Q: Farmer presents with SLUDGE, miosis, bradycardia after pesticide exposure: Organophosphate poisoning β†’ Atropine (large doses to dry secretions) + Pralidoxime (if given early).
Q: Patient on MAO inhibitors takes ephedrine β€” dangerous? MAO inhibition β†’ NE not degraded intraneuronally β†’ ephedrine releases massive NE stores β†’ hypertensive crisis.
Q: Cocaine + Ξ²-blocker in chest pain β€” why dangerous? Ξ²-block leaves Ξ± (vasoconstriction) unopposed β†’ worsens coronary spasm. Use phentolamine or benzodiazepines instead.
Q: Edrophonium test β€” patient's weakness improves β€” diagnosis? Myasthenia gravis (anti-AChR antibody disease). Weakness improves because more ACh is available at NMJ.
Q: Why does atropine cause tachycardia but physostigmine causes bradycardia? Atropine blocks M2 (vagal control) β†’ ↑HR. Physostigmine inhibits AChE β†’ ↑ACh β†’ M2 activation β†’ ↓HR.

PART 9 β€” MEMORY AIDS

MnemonicWhat it covers
SLUDGE / DUMBELSOrganophosphate / cholinergic excess signs
"Hot as a hare, Dry as a bone..."Atropine toxicity effects
"-olol" suffixAll Ξ²-blockers
"Ξ±1 constricts, Ξ±2 inhibits, Ξ²1 beats, Ξ²2 breathes/babies"Receptor actions
"Fight or flight" vs "Rest and digest"Sympathetic vs parasympathetic
Dopamine: D-M-H (Dilate-Moderate-High)Low dose D1 (dilate), Mid Ξ²1 (heart), High Ξ±1 (hypertension)
"PINCH" for Ξ²-blockers CIPulmonary (asthma), Insulin-masking, No (AV block), Cocaine, Heart failure (decompensated)

Sources: Lippincott Illustrated Reviews: Pharmacology, 8e Β· Katzung's Basic & Clinical Pharmacology, 16e Β· Guyton & Hall Medical Physiology

This covers the entire MBBS ANS pharmacology syllabus: anatomy/physiology of the ANS, cholinergic/adrenergic neurotransmission, all receptor types with second messengers, every drug class with mechanisms/uses/adverse effects, and exam-ready clinical scenarios. Let me know if you want any section expanded β€” for example, a deep-dive into Ξ²-blockers in heart failure, or a topic-wise MCQ drill.

Teach me everything I need to know as an MBBS student in CNS Pharmacology

Checking Date & Time
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Reading File
Reading File
Finding Sources
Finding Sources
Reading File
Your credits are exhausted. Your daily credits reset tomorrow, or you can purchase a top-up for more.

Component of pediatric clerking explained in details

Reading File
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
Here is your complete, detailed guide to Components of Pediatric Clerking, built from The Harriet Lane Handbook (Johns Hopkins), Textbook of Family Medicine, and standard pediatric clinical practice.

πŸ§’ Components of Pediatric Clerking β€” Complete MBBS Guide


What is Pediatric Clerking?

Clerking is the structured process of taking a full history, performing a physical examination, formulating a differential diagnosis, ordering investigations, and creating a management plan. Pediatric clerking differs from adult clerking in several important ways:
  • The historian is usually a parent/caregiver, not the patient (especially <8 years)
  • Developmental history is a mandatory component
  • Birth history and antenatal history are unique to pediatrics
  • Physical examination approach is age-dependent and must be child-friendly
  • Growth and nutritional assessment are core parts
  • Immunization history is always reviewed
  • Normal values (HR, BP, RR, weight) are age-specific

STRUCTURE OF PEDIATRIC CLERKING

1. Biodata
2. Presenting Complaint(s)
3. History of Presenting Complaint
4. Antenatal & Birth History
5. Neonatal History
6. Feeding & Nutritional History
7. Developmental History
8. Immunization History
9. Past Medical & Surgical History
10. Drug & Allergy History
11. Family History
12. Social & Environmental History
13. Systems Review
14. Physical Examination
15. Summary, Differential Diagnosis & Problem List
16. Investigations
17. Management Plan

SECTION 1 β€” BIODATA

Document for every patient:
FieldDetails
NameFull name
AgeState in months for children <2 years (e.g., "14 months"), years thereafter
SexMale / Female
Date of BirthDD/MM/YYYY
Weight / Length / Head circumferencePlot on growth chart
AddressHome/community
InformantName + relationship to child; assess reliability
Date of clerking
Age in months is critical β€” many drug doses, milestones, and normal values depend on exact age in months.

SECTION 2 β€” PRESENTING COMPLAINT(S)

  • List in the patient's/informant's own words, e.g., "fever and inability to walk for 3 days"
  • Record duration alongside each complaint
  • List in chronological or priority order (most serious first)

SECTION 3 β€” HISTORY OF PRESENTING COMPLAINT (HPC)

This is the most detailed section. Explore each complaint using SOCRATES or a structured approach:
For each symptom, ask:
  • Onset β€” sudden or gradual? When exactly did it start?
  • Duration β€” how long has it lasted?
  • Character β€” describe the symptom (e.g., type of cough, nature of fever)
  • Severity β€” how has it affected the child? Activity level? Feeding?
  • Progression β€” getting better, worse, or fluctuating?
  • Associated symptoms β€” ask about related systems
  • Aggravating / Relieving factors
  • Previous similar episodes
  • Treatment already given β€” home remedies, medications, herbal preparations

Pediatric-Specific Symptom Probes

Fever:
  • Onset, duration, pattern (continuous, intermittent, remittent)
  • Highest temperature measured? How measured?
  • Associated rigors, night sweats, rash, seizures?
  • Contact with ill persons? Travel history? Mosquito exposure?
  • Response to antipyretics?
Cough:
  • Duration (>2 weeks = chronic), nature (dry/productive), timing (nocturnal = asthma/pertussis)
  • Associated wheeze, stridor, difficulty breathing, cyanosis?
  • Foreign body aspiration history?
Diarrhea/Vomiting:
  • Frequency per day, consistency, blood or mucus in stool, offensive odor
  • Associated fever, pain, tenesmus
  • Signs of dehydration β€” last urine output, sunken eyes, dry mouth, lethargy
  • Recent food intake, other family members affected
Seizures:
  • Febrile or afebrile?
  • Type β€” focal or generalized (tonic, clonic, tonic-clonic, absence, myoclonic)
  • Duration, post-ictal state, frequency
  • Family history of seizures/epilepsy
  • Prior similar episodes, developmental status before seizures
Respiratory distress:
  • Work of breathing β€” grunting, nasal flaring, subcostal/intercostal recession?
  • Feeding difficulty (can't finish feeds = significant respiratory distress)
  • Stridor (inspiratory = upper airway; expiratory = lower airway)
  • Cyanosis?

SECTION 4 β€” ANTENATAL HISTORY

Ask the mother about the pregnancy:
AreaWhat to Ask
Antenatal careAttended ANC? How many visits? Where?
Gestational ageFull term (37–42 wks), preterm (<37 wks), post-term (>42 wks)
Maternal illnessesDiabetes, hypertension/pre-eclampsia, infections (malaria, UTI, TORCH infections), thyroid disease, epilepsy
Medications in pregnancyFolate, iron, antimalarials, antiepileptics, retroviral drugs
Substance useAlcohol, tobacco, illicit drugs
InfectionsHIV status (PMTCT given?), syphilis (VDRL), rubella, toxoplasmosis, CMV
Ultrasound findingsFetal anomalies detected? Polyhydramnios/oligohydramnios?
Maternal ageVery young (<16) or older (>35) β€” risk implications
ParityG_P_: gravidity and parity, previous pregnancy losses
TORCH infections: Toxoplasma, Other (syphilis, HIV, VZV), Rubella, CMV, Herpes β€” all associated with congenital abnormalities and IUGR.

SECTION 5 β€” BIRTH HISTORY (PERINATAL HISTORY)

AreaWhat to Ask
Mode of deliverySVD, instrumental (forceps/vacuum), C-section β€” reason?
Place of deliveryHospital, home, TBA
Birth weightRecord in kg; LBW = <2.5 kg; VLBW = <1.5 kg
Gestation at deliveryWeeks
Cry at birthImmediate? Delayed? Needed resuscitation?
Colour at birthPink, pale, blue (cyanosed)
APGAR scoreIf known (1 min and 5 min)
Complications at birthBirth asphyxia, meconium-stained liquor, prolonged labour, cord around neck, shoulder dystocia
Neonatal admissionNICU/SCBU β€” why? How long?
A birth weight should be compared with gestational age: SGA (small for gestational age), AGA, or LGA (large = macrosomia, suggests maternal diabetes).

SECTION 6 β€” NEONATAL HISTORY

Events in the first 28 days of life:
IssueSignificance
JaundiceOnset (day 1 = pathological; day 2–3 = physiological), duration, treatment (phototherapy/exchange transfusion), Rhesus incompatibility
Feeding difficulties in first daysInability to latch, poor suck β€” may indicate neurological compromise
InfectionsSepsis, meningitis, omphalitis, conjunctivitis
Respiratory distressTransient tachypnea of newborn (TTN), RDS, meconium aspiration
Fits/seizuresHypoglycemia, hypocalcemia, sepsis, HIE
Congenital anomalies noted at birthCleft, cardiac, skeletal, chromosomal
Screening doneNewborn screening (metabolic screen, hearing screen, pulse oximetry)
Vitamin K administrationPrevents hemorrhagic disease of newborn

SECTION 7 β€” FEEDING & NUTRITIONAL HISTORY

This is central to pediatrics β€” malnutrition is a leading cause of childhood morbidity.

For Infants:

QuestionWhy it Matters
Breastfed or formula?Breastfeeding = gold standard for first 6 months
Exclusive breastfeeding until what age?WHO recommends exclusive breastfeeding to 6 months
Frequency and duration of feeds
Complementary foods introduced when?Should start at 6 months alongside breastfeeding
Type of weaning foodsCaloric density, variety
Feeding difficultiesPoor latch, reflux, vomiting, refusal
Current dietWhat does the child eat in a typical day?

For Older Children:

  • Appetite β€” good, poor, or selective?
  • Dietary diversity β€” fruits, vegetables, proteins, carbohydrates
  • Pica (eating non-food substances β€” suggests iron deficiency or lead poisoning)
  • Food security β€” can the family afford adequate nutrition?
  • Recent weight loss or failure to thrive?

Assess Nutritional Status (WHO criteria):

ParameterHow to Classify
Weight-for-ageUnderweight if Z-score < βˆ’2
Height/Length-for-ageStunted if Z-score < βˆ’2
Weight-for-heightWasted if Z-score < βˆ’2
MUAC<115 mm = severe acute malnutrition in 6–59 months
OedemaBilateral pitting oedema = kwashiorkor component

SECTION 8 β€” DEVELOPMENTAL HISTORY

Development is assessed in 6 streams (Harriet Lane Handbook):
StreamDescription
Gross motorPosture, locomotion β€” walking, running, jumping
Fine motorHand-eye coordination, pincer grasp, drawing
LanguageUnderstanding (receptive) and speaking (expressive)
Personal-socialInteraction, play, eye contact, sharing
Cognitive / Visual-motorProblem solving, puzzles, shapes
Adaptive / Self-careFeeding self, toileting, dressing

Ask the parent:

  • "At what age did the child first sit without support?"
  • "When did the child walk independently?"
  • "When did the child say their first meaningful word? First sentences?"
  • "Does the child play with other children? Make eye contact?"
  • "Is the child toilet-trained?"
  • "Have you noticed any regression β€” losing skills they previously had?"

Key Developmental Milestones (from Harriet Lane):

AgeGross MotorFine MotorLanguageSocial
2 monthsHolds head up on tummyOpens hands brieflyCoos ("ooh", "aah")Social smile, responds to voice
4 monthsHolds head steady; pushes up on forearmsHolds rattle; swipes at objectsLaughs, babbles backRecognizes parent; shows interest
6 monthsRolls; sits with supportTransfers objects hand to handBabbles ("ba-ba")Laughs; recognizes strangers
9 monthsCrawls; pulls to standPincer grasp developing"Mama/dada" (non-specific); imitates soundsStranger anxiety; waves bye-bye
12 monthsWalks with support; cruisesNeat pincer grasp1–3 words with meaning; "mama/dada" specificSeparation anxiety; plays pat-a-cake
18 monthsWalks independently; runsScribbles; stacks 2–4 blocks10–25 words; names body partsParallel play; feeds self with spoon
2 yearsRuns; kicks a ballStacks 6 blocks; copies vertical line2-word phrases; 50+ wordsParallel play; follows 2-step commands
3 yearsClimbs stairs (alternate feet); rides tricycleCopies circle; holds pencilSentences (3+ words); strangers understandGroup play starts; shares toys
4 yearsHops on one foot; skipsCopies cross; draws person (3 parts)Tells stories; past/future tenseCooperative play; knows gender
5 yearsSkips; rides bike with training wheelsWrites name; copies squareFull sentences; counts to 10Follows rules; has friends

Developmental Red Flags (alarm signs β€” refer immediately):

AgeRed Flag
2 monthsNo social smile; no response to sound
6 monthsNo cooing or babbling; no head control
9 monthsNo sitting; no stranger anxiety; no babbling
12 monthsNo words; not standing with support; no pointing
18 months<10 words; no walking; no imitation
2 yearsNo 2-word phrases; no meaningful play
3 yearsCan't be understood by strangers; no 3-word sentences
Any ageLoss of previously acquired skills = regression β†’ urgent referral

SECTION 9 β€” IMMUNIZATION HISTORY

Always ask:
  1. Is the child up-to-date on vaccinations?
  2. Where is the vaccination card? (request it)
  3. Any adverse reactions to previous vaccines?
  4. Any reasons why vaccines may have been missed (illness, travel, refusal)?

WHO Expanded Programme on Immunization (EPI) β€” Standard Schedule:

AgeVaccines
BirthBCG, OPV-0 (birth dose), HBV-1
6 weeksOPV-1, Pentavalent-1 (DPT+HBV+HiB), PCV-1, Rotavirus-1
10 weeksOPV-2, Pentavalent-2, PCV-2, Rotavirus-2
14 weeksOPV-3, Pentavalent-3, PCV-3, IPV
9 monthsMeasles-Rubella (MR), Yellow Fever (in endemic areas), Meningococcal A
15–18 monthsMR booster, DPT booster
School ageTd (tetanus-diphtheria) boosters
Countries vary in schedules β€” always compare with your national EPI schedule.

SECTION 10 β€” PAST MEDICAL & SURGICAL HISTORY (PMH/PSH)

  • Previous illnesses (hospitalization, serious infections)
  • Previous surgeries β€” what, when, complications?
  • Chronic illnesses: asthma, sickle cell disease, epilepsy, diabetes, congenital heart disease
  • Recurrent infections (otitis media, pneumonia, UTI β€” may suggest immunodeficiency)
  • Previous blood transfusions

SECTION 11 β€” DRUG & ALLERGY HISTORY

Drug History:
  • Current medications β€” name, dose, route, frequency, duration
  • Herbal/traditional preparations (very common β€” must ask specifically)
  • Over-the-counter medications
  • Vitamins and supplements
Allergy History:
  • Drug allergies β€” specify drug, reaction type (rash, anaphylaxis, GI intolerance)
  • Food allergies β€” peanuts, eggs, milk protein
  • Environmental allergies β€” dust, pollen, animals

SECTION 12 β€” FAMILY HISTORY

  • Parents' health β€” chronic illnesses, similar symptoms
  • Siblings β€” number, ages, health status; any siblings died young (sudden death, unknown illness)?
  • Consanguinity β€” are parents related? (risk of autosomal recessive conditions)
  • Specific family diseases:
    • Sickle cell disease / trait
    • Tuberculosis (household contact)
    • Epilepsy / febrile seizures
    • Congenital heart disease
    • Genetic conditions (metabolic disorders, chromosomal)
    • Mental health conditions
    • Hypertension, diabetes, asthma

SECTION 13 β€” SOCIAL & ENVIRONMENTAL HISTORY

This section is particularly important in pediatrics as the child's environment profoundly shapes health:
DomainKey Questions
Living situationWho does the child live with? How many people in the household?
Socioeconomic statusPrimary breadwinner, income, occupation of parents
HousingType of house, crowding, ventilation, sanitation (toilet, source of water)
SchoolAttending school? Grade? Performance? Bullying?
CaregiverPrimary caregiver β€” parent, grandparent, nanny?
SmokingDoes anyone smoke in the household? (passive smoking β†’ recurrent respiratory illness)
PetsDogs, cats (allergies, zoonoses)
TravelRecent travel to malaria-endemic or high-risk areas?
StressesFamily dysfunction, domestic violence, recent losses
Child safeguardingAre there concerns about neglect or abuse? (mandatory to assess)

HEEADSSS Assessment (Adolescents β€” from Harriet Lane):

Used for adolescent patients (>10 years):
  • H β€” Home: household dynamics, stability, changes
  • E β€” Education/Employment: school performance, truancy, future plans
  • E β€” Eating: body image, dieting, eating disorders, food security
  • A β€” Activities: physical activity, hobbies, sleep, screen time, social media
  • D β€” Drugs: tobacco, alcohol, illicit substances, prescription misuse
  • S β€” Sexuality: sexual identity, activity, contraception, STI risk
  • S β€” Suicide/Depression: mood, self-harm, suicidal ideation, mental health
  • S β€” Safety: seatbelt, helmet use, violence exposure, abuse
Adolescent consultations should include one-on-one time (without the parent present) to allow confidential disclosure. Begin integrating this from age 11 years.

SECTION 14 β€” SYSTEMS REVIEW

A quick screen across all body systems to identify symptoms not mentioned in the HPC:
SystemKey Questions
CNSHeadaches, seizures, vision/hearing problems, weakness, behavioral changes
CVSPalpitations, cyanosis, exercise intolerance, edema, murmur known
RespiratoryCough, wheeze, stridor, difficulty breathing
GIAppetite, vomiting, diarrhea, constipation, abdominal pain, jaundice
GUDysuria, frequency, hematuria, enuresis (bedwetting), genital abnormalities
MSKJoint pain/swelling, limp, bone deformities, fractures
SkinRashes, itching, pallor, jaundice, hair/nail changes
EndocrineExcessive thirst/urination, weight changes, growth concerns, puberty onset
HaematologicalPallor, bleeding tendency, easy bruising, lymphadenopathy

SECTION 15 β€” PHYSICAL EXAMINATION

General Approach:

  • Make the child comfortable β€” examine on parent's lap when possible for young children
  • Start with least distressing examination first (observe, auscultate before palpating/percussing)
  • Examine the ears and throat last (most distressing)
  • Adapt examination to age and cooperation
  • Observe the parent-child interaction

A. General Examination

Look at the child before touching:
ObservationWhat to Note
General appearanceWell/unwell, alert/lethargic, agitated/irritable
Nutritional statusWasted, stunted, edematous, obese
Hydration statusSunken eyes, dry mucous membranes, skin turgor, anterior fontanelle (infants)
PallorConjunctival, palmar, tongue pallor β†’ anemia
JaundiceScleral icterus, skin (check in natural light)
CyanosisCentral (tongue/mucosa) vs peripheral (fingers); SpOβ‚‚
Respiratory distressTachypnea, grunting, nasal flaring, subcostal/intercostal recession, accessory muscle use
EdemaPeripheral (pitting or non-pitting), face (periorbital)
LymphadenopathyCervical, axillary, inguinal β€” generalized vs localized
SkinRashes, petechiae, purpura, birthmarks, lesions
Dysmorphic featuresDown syndrome facies, cleft palate, ear malformations

B. Vital Signs (Age-Specific Normal Values)

AgeHeart Rate (bpm)Respiratory Rate (breaths/min)Systolic BP (mmHg)
Newborn (0–1 mo)100–16030–6060–90
Infant (1–12 mo)100–15025–4070–100
Toddler (1–3 yr)90–15020–3080–110
Preschool (3–5 yr)80–14020–2580–110
School-age (6–12 yr)70–12015–2090–120
Adolescent (>12 yr)60–10012–18100–130
Temperature: Normal axillary = 36.5–37.2Β°C. Fever = β‰₯38Β°C. Rectal temperature is 0.5Β°C higher than axillary.

C. Anthropometry & Growth

Always measure and plot on a growth chart:
  • Weight (kg) β€” use calibrated scale; infant naked or in minimal clothing
  • Length/Height β€” length lying (< 2 years); standing height (β‰₯ 2 years)
  • Head circumference (OFC) β€” measure until age 3 years (frontal-occipital circumference)
  • MUAC (mid-upper arm circumference) β€” screen for acute malnutrition in 6–59 months
  • BMI β€” in older children and adolescents
Growth parameters to know:
MilestoneValue
Birth weight~3.0–3.5 kg average
Doubles birth weight~5 months
Triples birth weight~12 months
Quadruples birth weight~2 years
Birth length~50 cm
Length at 1 year~75 cm (~50% increase)
Adult height β‰ˆ2 Γ— height at age 2 years
Head circumference at birth~34 cm
Head circumference at 1 year~47 cm
Fontanelle closesPosterior: 6–8 wks; Anterior: 12–18 months

D. Systemic Examination

Cardiovascular:
  • Precordial inspection (heaves, deformity), palpation (apex beat, thrills), auscultation (S1, S2, murmurs)
  • Peripheral pulses (rate, rhythm, character, volume), capillary refill time (normal <2 sec)
  • Jugular venous pressure (JVP) in older children
  • Four-limb BP difference (coarctation of aorta)
  • Murmur grading (I–VI; thrill from grade IV onward)
Respiratory:
  • Inspection: shape of chest, recession, use of accessory muscles, symmetry
  • Palpation: tracheal position, chest expansion, vocal fremitus
  • Percussion: resonance, dullness, hyperresonance
  • Auscultation: breath sounds (vesicular, bronchial), adventitia (crackles, wheeze, pleural rub)
Abdominal:
  • Inspect: shape (scaphoid = malnutrition; distended = masses/organomegaly/ascites), umbilicus, hernias, dilated veins
  • Auscultate first (bowel sounds)
  • Palpate: light then deep; liver (starts from RIF moving up), spleen (starts from RIF moving to LUQ), kidneys (ballottement), bladder
  • Percuss: liver span, spleen, shifting dullness for ascites
  • Normal liver edge: palpable 1–2 cm below RCM in infants (normal variant)
Neurological:
  • Level of consciousness β€” AVPU (Alert, Voice, Pain, Unresponsive) or GCS (modified for children)
  • Anterior fontanelle β€” bulging (raised ICP) or sunken (dehydration)
  • Tone, power, reflexes (DTRs, plantar response)
  • Cranial nerves (test age-appropriate)
  • Cerebellar signs (older children)
  • Developmental assessment during examination
Musculoskeletal:
  • Limb deformities (genu varum/valgum, club foot, rickets)
  • Joint swelling, warmth, tenderness
  • Gait (observe child walk/run)
Ear, Nose & Throat (HEENT) β€” done last:
  • Eyes: conjunctival pallor, jaundice, red reflex (every newborn), strabismus, corneal clouding
  • Ears: otoscopy (TM appearance, discharge)
  • Nose: nasal flaring, discharge, deviated septum
  • Throat/mouth: tonsils (size, exudate), teeth, dental caries, oral thrush, cleft palate
  • Lymph nodes: cervical, tonsillar, preauricular
Genitalia & Anus (when clinically indicated):
  • Males: undescended testes, hydrocele, hypospadias, phimosis
  • Females: labial adhesions, ambiguous genitalia
  • Anus: anal fissures, perianal excoriation (pinworm), rectal prolapse
  • Always done with a chaperone present and explain to child/parent beforehand

SECTION 16 β€” SUMMARY & PROBLEM LIST

Write a concise summary in 3–5 sentences:
  • Age, sex, presenting complaint
  • Key positives in history
  • Key positives on examination
  • Relevant negatives
Then list your problems:
  1. Problem 1 (e.g., "Severe acute malnutrition with oedema")
  2. Problem 2 (e.g., "Febrile illness β€” possible malaria")
  3. Problem 3 (e.g., "Global developmental delay")

SECTION 17 β€” DIFFERENTIAL DIAGNOSIS

List in order of likelihood with brief justification for each. For example:
  1. Cerebral malaria β€” fever + seizures + altered consciousness in malaria-endemic area
  2. Bacterial meningitis β€” fever + neck stiffness + bulging fontanelle
  3. Febrile seizure β€” age 6 months–5 years, simple first seizure with fever

SECTION 18 β€” INVESTIGATIONS

Tailor investigations to the likely diagnosis. Common pediatric investigations:
CategoryTests
HaematologyFBC + differential, PCV/haematocrit, blood smear (malaria), reticulocyte count, sickle cell screen
BiochemistryBlood glucose (ALWAYS in sick child), electrolytes, urea, creatinine, LFTs, calcium, phosphate
MicrobiologyBlood culture, urine culture (MSU), CSF analysis (if meningitis suspected), stool MC&S
ImagingChest X-ray (pneumonia, TB, cardiac), abdominal USS, skull X-ray, bone age
SpecialisedMantoux test (TB), serum ferritin (iron deficiency), lead levels, thyroid function

SECTION 19 β€” MANAGEMENT PLAN

Follow the SOAP framework or use 3 pillars:
  1. Resuscitation / immediate stabilisation (if sick child β€” ABC, fluids, glucose)
  2. Definitive treatment (antimicrobials, specific drugs, nutrition rehabilitation, surgery)
  3. Supportive care (antipyretics, hydration, nutritional support, pain relief)
  4. Preventive measures / anticipatory guidance (vaccines, insecticide-treated nets, hand washing, deworming)
  5. Follow-up plan (when to review, what to watch for, when to return urgently)
  6. Counselling (explain diagnosis and treatment to parent in understandable terms)

QUICK REFERENCE: Pediatric Clerking vs Adult Clerking

FeaturePediatricAdult
HistorianParent/caregiver (child adds from ~8 years)Patient
Birth & antenatal historyMandatoryNot applicable
Developmental historyMandatoryNot applicable
Immunization historyMandatoryLess critical
Nutritional/feeding historyCore componentLess prominent
Growth assessmentMust plot growth chartNot routinely done
Normal vital signsAge-dependentFixed adult ranges
Drug dosesWeight-based (mg/kg)Fixed standard doses
Examination techniqueChild-friendly, age-adaptedStandard approach
ConfidentialityFrom ~11 years (adolescents)Always

Sources: The Harriet Lane Handbook, Johns Hopkins Hospital, 23rd Edition Β· Textbook of Family Medicine, 9th Edition Β· WHO Child Growth Standards Β· AAP Bright Futures Guidelines

This covers every component you need for pediatric clerking at the MBBS level β€” from biodata to management. Let me know if you want any section expanded further, such as developmental milestones in more detail, the HEEADSSS adolescent assessment, or the WHO malnutrition classification system.
This is a shared conversation. Sign in to Orris to start your own chat.